| Aparna M Mele, MD | |
|
1011 Reed Ave, Suite 300, Wyomissing, PA 19610-2002 | |
| (610) 374-4401 | |
| (610) 374-7140 |
| Full Name | Aparna M Mele |
|---|---|
| Gender | Female |
| Speciality | Gastroenterology |
| Experience | 23 Years |
| Location | 1011 Reed Ave, Wyomissing, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851512719 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | MD431285 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Reading Hospital | West reading, PA | Hospital |
| Pottstown Hospital | Pottstown, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Regional Gastroenterology Associates Of Lancaster, Ltd. | 4688575434 | 236 |
News Archive
Tobira Therapeutics Inc., a clinical stage biotechnology company committed to research and product discovery for the treatment of life-threatening and life-altering infectious diseases, today announced pharmacokinetic data and results from a double-blind, placebo-controlled, multiple-dose randomized study of TBR-652 in sixty healthy volunteers.
Women continue to be underrepresented in leadership roles, a dilemma a new study suggests could be helped by eliminating self-nomination from competitive selection processes.
Soligenix, Inc., formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today that it has initiated enrollment in its confirmatory Phase 3 randomized, double-blind, placebo-controlled, multicenter clinical trial evaluating orBec(®) for the treatment of acute gastrointestinal Graft-versus-Host disease (GI GVHD).
The Globe and Mail on Tuesday examined how "state-sponsored" discrimination and stigma against men who have sex in men in Senegal has "shattered" HIV/AIDS programs aimed at the high-risk group.
Keto, gluten-free, organic: If a pet owner is on a specific diet, chances are their dog is on it, too, a new U of G study reveals. But when it comes to a grain-free diet, owners seem to choose it more for their dogs than themselves, the study also found.
› Verified 6 days ago
| Entity Name | Regional Gastroenterology Associates Of Lancaster, Ltd. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154422806 PECOS PAC ID: 4688575434 Enrollment ID: O20040115000777 |
News Archive
Tobira Therapeutics Inc., a clinical stage biotechnology company committed to research and product discovery for the treatment of life-threatening and life-altering infectious diseases, today announced pharmacokinetic data and results from a double-blind, placebo-controlled, multiple-dose randomized study of TBR-652 in sixty healthy volunteers.
Women continue to be underrepresented in leadership roles, a dilemma a new study suggests could be helped by eliminating self-nomination from competitive selection processes.
Soligenix, Inc., formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today that it has initiated enrollment in its confirmatory Phase 3 randomized, double-blind, placebo-controlled, multicenter clinical trial evaluating orBec(®) for the treatment of acute gastrointestinal Graft-versus-Host disease (GI GVHD).
The Globe and Mail on Tuesday examined how "state-sponsored" discrimination and stigma against men who have sex in men in Senegal has "shattered" HIV/AIDS programs aimed at the high-risk group.
Keto, gluten-free, organic: If a pet owner is on a specific diet, chances are their dog is on it, too, a new U of G study reveals. But when it comes to a grain-free diet, owners seem to choose it more for their dogs than themselves, the study also found.
› Verified 6 days ago
| Entity Name | Digestive Disease Associates, Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699742080 PECOS PAC ID: 3375526049 Enrollment ID: O20040611001399 |
News Archive
Tobira Therapeutics Inc., a clinical stage biotechnology company committed to research and product discovery for the treatment of life-threatening and life-altering infectious diseases, today announced pharmacokinetic data and results from a double-blind, placebo-controlled, multiple-dose randomized study of TBR-652 in sixty healthy volunteers.
Women continue to be underrepresented in leadership roles, a dilemma a new study suggests could be helped by eliminating self-nomination from competitive selection processes.
Soligenix, Inc., formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today that it has initiated enrollment in its confirmatory Phase 3 randomized, double-blind, placebo-controlled, multicenter clinical trial evaluating orBec(®) for the treatment of acute gastrointestinal Graft-versus-Host disease (GI GVHD).
The Globe and Mail on Tuesday examined how "state-sponsored" discrimination and stigma against men who have sex in men in Senegal has "shattered" HIV/AIDS programs aimed at the high-risk group.
Keto, gluten-free, organic: If a pet owner is on a specific diet, chances are their dog is on it, too, a new U of G study reveals. But when it comes to a grain-free diet, owners seem to choose it more for their dogs than themselves, the study also found.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Aparna M Mele, MD 1011 Reed Ave, Suite 300, Wyomissing, PA 19610-2002 Ph: (610) 374-4401 | Aparna M Mele, MD 1011 Reed Ave, Suite 300, Wyomissing, PA 19610-2002 Ph: (610) 374-4401 |
News Archive
Tobira Therapeutics Inc., a clinical stage biotechnology company committed to research and product discovery for the treatment of life-threatening and life-altering infectious diseases, today announced pharmacokinetic data and results from a double-blind, placebo-controlled, multiple-dose randomized study of TBR-652 in sixty healthy volunteers.
Women continue to be underrepresented in leadership roles, a dilemma a new study suggests could be helped by eliminating self-nomination from competitive selection processes.
Soligenix, Inc., formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today that it has initiated enrollment in its confirmatory Phase 3 randomized, double-blind, placebo-controlled, multicenter clinical trial evaluating orBec(®) for the treatment of acute gastrointestinal Graft-versus-Host disease (GI GVHD).
The Globe and Mail on Tuesday examined how "state-sponsored" discrimination and stigma against men who have sex in men in Senegal has "shattered" HIV/AIDS programs aimed at the high-risk group.
Keto, gluten-free, organic: If a pet owner is on a specific diet, chances are their dog is on it, too, a new U of G study reveals. But when it comes to a grain-free diet, owners seem to choose it more for their dogs than themselves, the study also found.
› Verified 6 days ago
Nirav R. Shah, MD, MPH Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1011 Reed Ave, Suite 300, Wyomissing, PA 19610 Phone: 610-374-4401 Fax: 610-374-7140 | |
Dr. David F Steffy, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 950b N Wyomissing Blvd, 3rd Floor, Wyomissing, PA 19610 Phone: 610-898-1820 Fax: 610-372-0164 | |
Dr. Michael Bernard Russo, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2605 Keiser Blvd, Wyomissing, PA 19610 Phone: 610-685-8500 Fax: 610-685-4833 | |
Dr. Pallak Agarwal, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2608 Keiser Blvd, Wyomissing, PA 19610 Phone: 610-685-5864 Fax: 610-929-1528 | |
Dr. Kristie Marie Pepper, D.O. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2760 Century Blvd, Wyomissing, PA 19610 Phone: 610-375-4251 Fax: 610-685-2870 | |
Louis La Luna, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1011 Reed Ave, Suite 300, Wyomissing, PA 19610 Phone: 610-374-4401 Fax: 610-374-7140 | |
Tara Lynn Dimino, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 2605 Keiser Blvd, Wyomissing, PA 19610 Phone: 610-685-8500 Fax: 610-685-4833 |